Key result
Pharmacist transitions of care linked to fewer COPD hospitalizations and ED visits vs usual care.
Why the study?
Mortality risk from COPD increases significantly in the first year after a 30-day hospital readmission.
Does a comprehensive and collaborative pharmacist transitions of care service reduce a 180-day composite of COPD-related hospitalizations and ED visits in underserved adult patients hospitalized with COPD exacerbation?
Observational (n=65)
No
Does a comprehensive and collaborative pharmacist transitions of care service reduce a 180-day composite of COPD-related hospitalizations and ED visits in underserved adult patients hospitalized with COPD exacerbation?
Answers are grounded in this paper and cite their sources.
A comprehensive pharmacist transitions of care service significantly reduces 30-day COPD-related hospital readmissions and ED visits in underserved patients.
BACKGROUND: Mortality risk from chronic obstructive pulmonary disease (COPD) increases significantly in the first year after a 30-day hospital readmission. OBJECTIVE: To evaluate a comprehensive and collaborative pharmacist transitions of care service for patients hospitalized with COPD compared to usual care. METHODS: In this within-site, retrospective study, discharge counseling, medication reconciliation, medication access assistance, therapy changes, and post-discharge long-term follow-up were provided to underserved adult patients with a primary care provider at the study clinic and admitted to the affiliated hospital with a primary diagnosis of COPD exacerbation. Primary outcome was a 180-day composite of COPD-related hospitalizations and emergency department (ED) visits. Secondary outcomes were 30-, 60-, 90-, and 180-day events, costs, pharmacist interventions, time to follow-up, and pneumonia. There was no significant difference in time to follow-up or pneumonia. CONCLUSIONS: A comprehensive, collaborative pharmacist transitions of care service significantly reduced 30-day COPD-related hospital readmissions, ED re-visits, and associated costs in an underserved population.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) conducted an observational in Chronic Obstructive Pulmonary Disease (COPD) exacerbation (n=65). Comprehensive and collaborative pharmacist transitions of care service vs. Usual care was evaluated on 180-day composite of COPD-related hospitalizations and emergency department (ED) visits (Mean difference 0.82, 95% CI 0.05-1.60, p=0.0364). A comprehensive pharmacist transitions of care service significantly reduced the 180-day composite of COPD-related hospitalizations and ED visits compared to usual care (mean difference 0.82).
Synapse has enriched 10 related papers. Consider them for comparative context: